Do we understand voiding dysfunction in women? Current understanding and future perspectives: ICI-RS 2017

Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Panicker, JN
- Anding, R
- Blok, B
- Dorrepaal, C
- Harding, C
- Marcelissen, T
- Rademakers, K
- Abrams, P
- Apostolidis, A
Grupos
Abstract
AimsUrinary retention in women is poorly understood, compared to the equivalent condition in men, and was the subject of a dedicated session organized at the International Consultation on Incontinence Research Society (ICI-RS) in Bristol, United Kingdom, 2017. MethodsThe current understanding of the pathophysiological correlates of idiopathic voiding dysfunction in women, the role of urodynamics, neurophysiology, and non-invasive tests in characterizing functional bladder outlet obstruction due to a non-relaxing urethral sphincter, and poorly defined diagnosis of detrusor underactivity were reviewed. ResultsPutative factors underlying the pathogenesis of urinary retention following urinary tract infections were discussed. Further research is required to explore the association between bladder wall inflammation and alterations in detrusor contractile functions. The complex interrelationship between urinary retention and psychological co-morbidities and sexual trauma were explored, and the overlap between these and psychological co-morbidities and functional neurological problems with functional urological problems were recognized. Understanding the mechanism of action of sacral neuromodulation, often a successful treatment for urinary retention, would provide insight into the underlying factors that may be responsible for urinary retention. Specifically, there is a need to understand the role of the endogenous enkephalinergic system in the pathogenesis of urinary retention and to identify predictors of successful treatment with sacral neuromodulation. Based on current understanding and potential directions of research in the future, an algorithm for the evaluation of women with voiding dysfunction was proposed. ConclusionsIn the future, recommendations for research should lead to a better understanding of urinary retention in women and its treatment.
Datos de la publicación
- ISSN/ISSNe:
- 0733-2467, 1520-6777
- Tipo:
- Article
- Páginas:
- 75-85
- DOI:
- 10.1002/nau.23709
- Factor de Impacto:
- 0,985 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
NEUROUROLOGY AND URODYNAMICS WILEY
Citas Recibidas en Web of Science: 14
Documentos
- No hay documentos
Filiaciones
Keywords
- dysfunctional voiding; Fowler's syndrome; opiates; psychological co-morbidities; sacral neuromodulation; sexual abuse; urinary tract infections; voiding dysfunction
Proyectos asociados
CATETERISMO INTERMITENTE, CUMPLIMENTO Y ADHERENCIA EN ESPAÑA.
Investigador Principal: SALVADOR ARLANDIS GUZMÁN
CICAE . 2017
ESTUDIO FASE 2A, ALEATORIZADO, DOBLE CIEGO, CONTROLADO CON PLACEBO, DE GRUPOS PARALELOS, PRUEBA DE CONCEPTO PARA INVESTIGAR LA EFICACIA, LA SEGURIDAD, LA FARMACODINÁMICA Y LA FARMACOCINÉTICA DE ASP6294 EN EL TRATAMIENTO DE MUJERES CON SÍNDROME DE VEJIGA DOLOROSA/CISTITIS INTERSTICIAL.
Investigador Principal: SALVADOR ARLANDIS GUZMÁN
6294-CL-0101 . 2017
ESTUDIO DE EVALUACION DE LA FACTIVILIDAD, VALIDEZ Y FIABILIDAD DEL DIARIO MICCIONAL DE 3 DIAS, EN MUJERES ATENDIDAS EN UNIDADES DE UROLOGIA FUNCIONAL Y URODINAMICA. ESTUDIO DM3D.
Investigador Principal: SALVADOR ARLANDIS GUZMÁN
VH01-10 . 2011
ESTUDIO SOBRE PRÁCTICA CLÍNICA HABITUAL EN PACIENTES CON SÍNDROME DE DOLOR VESICAL (SDV) EN UNIDADES DE UROLOGÍA FUNCIONAL Y URODINÁMICA.
Investigador Principal: SALVADOR ARLANDIS GUZMÁN
AST-URO-13-02 . 2014
ESTUDIO DE EVALUACION DE LA VEJIGA HIPERACTIVA Y HIPERACTIVIDAD DEL DETRUSOR EN VARONES CON SINTOMAS DEL TRACTO URINARIO INFERIOR (STUI) DE LLENADO QUE ACUDEN A UNIDADES DE UROLOGIA FUNCIONAL Y URODINAMICA.
Investigador Principal: SALVADOR ARLANDIS GUZMÁN
VH02-11 . 2011
Cita
Panicker JN,Anding R,Arlandis S,Blok B,Dorrepaal C,Harding C,Marcelissen T,Rademakers K,Abrams P,Apostolidis A. Do we understand voiding dysfunction in women? Current understanding and future perspectives: ICI-RS 2017. Neurourol Urodyn. 2018. 37. (S4):p. 75-85. IF:2,360. (2).